Evidence map›Paper›PMID 27253522›Full record

Trial reportScientific reports2016

Predictive value of the composition of the vaginal microbiota in bacterial vaginosis, a dynamic study to identify recurrence-related flora.

Bingbing Xiao, Xiaoxi Niu, Na Han, Ben Wang, Pengcheng Du, Risu Na, Chen Chen, Qinping Liao

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Orally administratedFrontiers in immunology · 2023
    Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Log (Bioengineered · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Frontiers in cellular and infection microbiology · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Bingbing XiaoDepartment of Obstetrics and Gynecology, Peking University First Hospital, Xi'anmen Street, Beijing 100034, China.
Xiaoxi NiuDepartment of Obstetrics and Gynecology, Peking University First Hospital, Xi'anmen Street, Beijing 100034, China.
Na HanState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Ben WangDepartment of Obstetrics and Gynecology, Peking University First Hospital, Xi'anmen Street, Beijing 100034, China.
Pengcheng DuBeijing Key Laboratory of Emerging Infectious Diseases, Beijing 100015, China.
Risu NaDepartment of Obstetrics and Gynecology, Peking University First Hospital, Xi'anmen Street, Beijing 100034, China.
Chen ChenState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Qinping LiaoDepartment of Obstetrics and Gynecology, Peking University First Hospital, Xi'anmen Street, Beijing 100034, China.
Peking University · CNCapital Medical University · CNBeijing Tsinghua Chang Gung Hospital · CNNational Institute for Communicable Disease Control and Prevention · CNPeking University First Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial vaginosis (BV) is a highly prevalent disease in women, and increases the risk of pelvic inflammatory disease. It has been given wide attention because of the high recurrence rate. Traditional diagnostic methods based on microscope providing limited information on the vaginal microbiota increase the difficulty in tracing the development of the disease in bacteria resistance condition. In this study, we used deep-sequencing technology to observe dynamic variation of the vaginal microbiota at three major time points during treatment, at D0 (before treatment), D7 (stop using the antibiotics) and D30 (the 30-day follow-up visit). Sixty-five patients with BV were enrolled (48 were cured and 17 were not cured), and their bacterial composition of the vaginal microbiota was compared. Interestingly, we identified 9 patients might be recurrence. We also introduced a new measurement point of D7, although its microbiota were significantly inhabited by antibiotic and hard to be observed by traditional method. The vaginal microbiota in deep-sequencing-view present a strong correlation to the final outcome. Thus, coupled with detailed individual bioinformatics analysis and deep-sequencing technology, we may illustrate a more accurate map of vaginal microbial to BV patients, which provide a new opportunity to reduce the rate of recurrence of BV.

Indexed as

MicrobiotaAdolescentAdultAnti-Bacterial AgentsFemaleFollow-Up StudiesHigh-Throughput Nucleotide SequencingHumansMiddle AgedPredictive Value of TestsVaginosis, BacterialAnti-Bacterial Agents

Identifiers

PMID27253522
PMCPMC4890590
OpenAlexW2466257012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.